SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (237)9/5/2000 2:03:38 PM
From: scaram(o)uche   of 2243
 
The
Company had three customers each accounting for over 10% of
fiscal 2000 revenue-F. Hoffman-La Roche, Ltd., UCB-Bioproducts
S.A. and Searle, which individually accounted for approximately
29%, 19% and 14%, respectively, of the Company's fiscal 2000
revenues.

No mention of Aventis, but this is the sort of info that I was digging for.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News